Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fast-Track Therapeutic Model in Complicated Pediatric Appendicitis
2025-520777-39-00Phase 4Authorised
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin + clavulanate in acute appendicitis (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Composite adverse events within 30 postoperative days. Planned start Jan 2025; status: authorised.
02
Drugs
amoxicillin + clavulanate
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on 2025-520777-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520777-39-00.